April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Referral Source, Symptoms and Disease Severity at Initial Diagnosis of Ocular Hypertension or Open-Angle Glaucoma
Author Affiliations & Notes
  • Yvonne M. Buys
    Dept of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Ontario, Canada
  • Rania Gaspo
    Pfizer Canada, Kirkland, Quebec, Canada
  • Kenneth Kwok
    Statistics, Pfizer, New York, New York
  • Canadian Glaucoma Risk Factor Study Group
    Dept of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships  Yvonne M. Buys, Pfizer Canada (F); Rania Gaspo, Pfizer Canada (E); Kenneth Kwok, Pfizer Inc. (E)
  • Footnotes
    Support  Pfizer Canada
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5048. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yvonne M. Buys, Rania Gaspo, Kenneth Kwok, Canadian Glaucoma Risk Factor Study Group; Referral Source, Symptoms and Disease Severity at Initial Diagnosis of Ocular Hypertension or Open-Angle Glaucoma. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5048.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the severity of glaucoma at presentation and relationship to referral source and reason for referral.

Methods: : Prospective, Canadian multi-center, cross-sectional study. Consecutive consenting patients with newly diagnosed ocular hypertension (OH) or open-angle glaucoma (OAG) underwent a comprehensive ocular examination including medical history and presenting symptoms. Patient demographics and referral source were also obtained. Patients were classified as OH or mild, moderate or advanced glaucoma based on the Canadian Ophthalmological Society glaucoma guidelines. The proportion of subjects presenting in each disease category was determined. Disease severity at presentation was compared for differences in demographics, baseline ocular findings, referral source and symptoms.

Results: : 404 subjects with newly diagnosed OH or OAG were enrolled. A total of 113 (28%) were diagnosed as OH and 291 (72%) as OAG. In the OAG group 151 (52%) had mild, 79 (27%) moderate and 61 (21%) advanced disease at initial diagnosis. The majority of the referrals were from optometrists (82%) followed by family physicians (7%) and ophthalmologists (7%). Referral patterns were significantly different for advanced disease as compared to the other severity levels (p=0.02). Optometrists were responsible for 83, 86, 80 and 70% of the referrals for OH, mild, moderate and advanced OAG respectively while ophthalmologists made 9, 5, 3 and 15% of these same referrals. The reason of referral for the advanced was significantly different than the other disease levels (p<0.0001). In more than half of the subjects the referral was made as a result of an abnormality noted by the referring source in an asymptomatic patient. The second most common reason for referral was the presence of risk factors. Visual symptoms noted by the subject was more common in the advanced (21%) disease as compared to OH (7%), mild (3%) and moderate (9%) disease.

Conclusions: : Nearly half of the subjects with newly diagnosed OAG had moderate or advanced disease at the time of initial diagnosis. Although optometrists were responsible for the majority of the referrals this proportion was significantly less for those with advanced disease. These results raise the possibility of suboptimal detection services for glaucoma.

Keywords: clinical (human) or epidemiologic studies: health care delivery/economics/manpower • clinical (human) or epidemiologic studies: prevalence/incidence • clinical (human) or epidemiologic studies: natural history 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×